破裂性胸降主动脉腔内修复与开放手术临床结局比较
该系统综述与Meta分析纳入18项观察性试验共2088例患者(TEVAR组560例,OS组1528例),比较腔内修复与开放手术治疗破裂性胸降主动脉的安全性与有效性。结果显示TEVAR组围术期死亡率、1年死亡率、肾功能不全发生率和肺部并发症均低于开放手术组,但晚期再干预率更高。
要点
- TEVAR组围术期死亡率低于OS组(OR=0.47,95%CI 0.34-0.66,p<0.01)。
- TEVAR组1年死亡率低于OS组(OR=0.46,95%CI 0.29-0.75,p<0.01)。
- TEVAR组晚期再干预率高于OS组。
核心结论
- 在修复破裂性胸降主动脉时,TEVAR可能可以快速且安全地实施。
- 与OS相比,TEVAR与更低的围术期发病率和早期术后并发症发生率相关。
研究设计与样本
- 系统综述与Meta分析,检索PubMed、Embase和Cochrane Library数据库。
- 纳入18项观察性试验,共2088例患者(TEVAR组560例,OS组1528例)。
- 采用固定效应模型计算不同研究汇总结局的比值比(OR)及95%置信区间(CI)。
主要发现
- TEVAR组围术期死亡率低于OS组(OR=0.47;95%CI 0.34-0.66;p<0.01)。
- TEVAR组1年死亡率低于OS组(OR=0.46;95%CI 0.29-0.75;p<0.01)。
- TEVAR组肾功能不全发生率低于OS组(OR=0.56;95%CI 0.33-0.93;p=0.03)。
- TEVAR组肺部并发症发生率低于OS组(OR=0.69;95%CI 0.52-0.92;p=0.01)。
- TEVAR组与OS组在截瘫、卒中、肺栓塞、心脏并发症及早期再干预率方面无显著差异;但TEVAR组晚期再干预率高于OS组。
关键数值与推荐
- 围术期死亡定义为30天院内死亡。
- 比较参数包括围术期死亡率、1年死亡率、截瘫或轻瘫、肾功能不全、卒中、肺栓塞、再干预率、肺部并发症和心脏并发症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The comparisons between thoracic endovascular aortic repair for ruptured thoracic aorta (TEVAR) and open surgery (OS) have not been well documented, although both procedures have been widely utilized. We performed a systematic review and meta-analysis to investigate the effectiveness and safety between TEVAR and OS in the repair of ruptured descending thoracic aorta. METHODS: PubMed, Embase, and Cochrane Library databases were searched to find relevant studies to assess TEVAR and OS outcomes. The comparative parameters were perioperative mortality (30 day/in-hospital), 1 year mortality, paraplegia or paraparesis, renal insufficiency, stroke, pulmonary embolism, re-intervention rate, pulmonary complications, and cardiac complications. A fixed-effects model was applied to calculate the odds ratio (OR) with a 95% confidence interval (CI) on pooled outcomes from different studies. RESULTS: Eighteen observational trials involving 2088 patients were evaluated (TEVAR=560; OS=1528). Meta-analysis showed that TEVAR in repairing the ruptured descending thoracic aorta was associated with lower perioperative mortality (OR=0.47; 95% CI: 0.34-0.66; p<0.01), 1 year mortality (OR=0.46; 95% CI: 0.29-0.75; p<0.01), renal insufficiency incidence (OR=0.56; 95% CI: 0.33-0.93; p=0.03), and pulmonary complications (OR=0.69; 95% CI: 0.52-0.92; p=0.01) when compared with OS. There was no significant difference between TEVAR and OS in terms of paraplegia, stroke, pulmonary embolism, cardiac complications, and early re-intervention rates. However, the late re-intervention rate was higher in the TEVAR group than that in the OS group. CONCLUSIONS: When repairing the ruptured descending thoracic aorta, TEVAR may be performed rapidly and safely. TEVAR is associated with lower rates of perioperative morbidity and early postoperative complications than OS.
引用
- Xie X, Shu X, Zhang W, et al. A Comparison of Clinical Outcomes of Endovascular Repair Versus Open Surgery for Ruptured Descending Thoracic Aorta. J Endovasc Ther. 2021. PMID: 34779300. doi:10.1177/15266028211057087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。